Browsing Tag
Exparel
3 posts
How the NOPAIN Act could support broader reimbursement momentum for EXPAREL
Could the NOPAIN Act accelerate EXPAREL adoption in outpatient orthopedic surgery? Explore the reimbursement and opioid-reduction implications.
How opioid reduction strategies are driving cost savings in orthopedic surgery pathways
Find out how Pacira BioSciences, Inc. is using EXPAREL data to drive opioid reduction and cost savings in Medicare orthopedic surgery pathways.
Can ATX101 disrupt the multibillion-dollar post-surgical pain market?
Can Allay Therapeutics’ ATX101 replace opioids in post-surgical care? Read how this long-acting bupivacaine platform may disrupt the pain relief market by 2026.